Sogo Oki, Yukitomo Ishi, Ryosuke Sawaya, Michinari Okamoto, Hiroaki Motegi, Zen-Ichi Tanei, Masumi Tsuda, Takashi Mori, Kentaro Nishioka, Hiromi Kanno-Okada, et al. Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults. Acta neurochirurgica. 2024. 166. 1. 263-263
Keishi Fujiwara, Shinya Morita, Hiroaki Motegi, Shigeru Yamaguchi, Yukitomo Ishi, Kimiko Hoshino, Atsushi Fukuda, Makoto Kobayashi, Yuji Nakamaru, Miki Fujimura, et al. Pre- and post-operative semicircular canal function evaluated by video head impulse test in patients with vestibular schwannoma. Auris, nasus, larynx. 2024. 51. 3. 542-547
Ryosuke Sawaya, Shigeru Yamaguchi, Yukitomo Ishi, Michinari Okamoto, Sumire Echizenya, Hiroaki Motegi, Noriyuki Fujima, Miki Fujimura. Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema. Journal of neurosurgery. 2024. 1-8
Michinari Okamoto, Shigeru Yamaguchi, Ryosuke Sawaya, Sumire Echizenya, Yukitomo Ishi, Sadahiro Kaneko, Hiroaki Motegi, Takuya Toyonaga, Kenji Hirata, Miki Fujimura. Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of 18F-Fluoromisonidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography. BioMed research international. 2024. 2024. 2973407-2973407
Akira Nakazono, Hiroaki Motegi, Masanobu Suzuki, Yuji Nakamaru, Shigeru Yamaguchi, Yukitomo Ishi, Satoshi Kano, Nayuta Tsushima, Aya Honma, Takayoshi Suzuki, et al. Clinical outcomes for olfactory neuroblastoma. Frontiers in oncology. 2024. 14. 1329572-1329572